Here at Juniper Pharma Services, we hold an MIA (investigational medicinal products) license for the manufacture, testing and certification of products for use in human clinical trials and we have equipment suitable for provision of IMP’s for Phase I and Phase II studies.
In the summer of 2012, our 30,000sq ft. clinical manufacturing facility opened its doors following a successful inspection from the Medicines and Healthcare products Regulatory Agency (MHRA). Our new site added six GMP suites, new laboratories and a dedicated clinical packing area to our existing capabilities.
Supporting clients’ clinical trial needs up to phase IIb, our site enables us to manufacture a range of dosage forms including:
We can handle a range of non-sterile dosage forms such as solids, liquids, semi-solids and inhaled products, including:
Our clinical trial manufacturing services are supported by our analytical and our advanced materials characterisation services. If you’re looking for an outsourced clinical manufacturing partner, then contact us today.